Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELENIB: Selenium and Vitamin E in Bladder Cancer
NCT00553124Phase 3Unknown
- Sponsor
- University Hospitals Birmingham
- Start
- Dec 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of selenium and vitamin e in bladder cancer (4 arms), sponsored by University Hospitals Birmingham. Primary endpoints: Recurrence-free interval and Progression-free interval. Status: unknown.
02
Drugs
seleniumvitamin e
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00553124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553124.